ESPR

No, the Biotech Boom Isn’t Over

By Ben LevisohnRBC’s Michael Yee and team aren’t too worried about biotech stocks like Gilead Sciences (GILD), Celgene (CELG), and Biogen Idec (BIIB) despite the biotech sector’s big drop last week:
Biotech felt another volatile pullback (similar to March) in the last week of April, pulling back 9% in a week. Investors had their helmets on as we went right through […]

Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports First Quarter 2014 Financial Results

[Business Wire] – Esperion Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of hypercholesterolemia, t moreView todays social media effects on ESPRView the latest stocks trending across Twitter. Click to view dashboardSee who Esperion is hiring next, click here to view […]

Esperion Therapeutics to Present at Bank of America Merrill Lynch Healthcare Conference

[Business Wire] – Esperion Therapeutics, Inc. today announced the Company will present at the 2014 Bank of America Merrill Lynch Healthcare Conference in Las Vegas, Nev. Tim M. Mayleben, president and chief executive officer, will provide updates on the moreView todays social media effects on ESPRView the latest stocks trending across Twitter. Click to view dashboardSee who Esperion is […]

Esperion Therapeutics to Provide First Quarter 2014 Financial Results

[Business Wire] – Esperion Therapeutics, Inc. today announced that it will host a conference call and webcast to report first quarter 2014 operational and financial results. The webcast will take place on Monday, May 12, 2014 at 4:30 p.m. moreView todays social media effects on ESPRView the latest stocks trending across Twitter. Click to view dashboardSee who Esperion is hiring […]

Esperion Therapeutics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Tim Mayleben Thank you, Mindy. I’d also like to welcome all of you to Esperion’s first quarterly conference call. On today’s call I’ll provide an overall update on the ETC-1002 development program and … moreView todays social media effects on ESPRView the latest stocks trending across Twitter. Click to view dashboardSee who Esperion is hiring next, […]